Approval · Notice of Compliance 12098 · 2011
NASONEX: Notice of Compliance 12098
Issued February 18, 2011
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 12098
- Date
- February 18, 2011
- Company
- Merck Canada IncKirkland, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Corticosteroid
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| NASONEX | 02238465 | Marketed |
Medicinal ingredients
- MOMETASONE FUROATE 50 MCG per SPR